Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Melphalan for Retinoblastoma
NCT01293539Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in retinoblastoma (Rb), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Mar 2011; status: terminated.
02
Drugs
melphalan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT01293539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293539.